1. CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignancies. (June 2017) Authors: Remon, J.; Abedallaa, N.; Taranchon-Clermont, E.; Bluthgen, V.; Lindsay, C.R.; Besse, B.; Thomas de Montpréville, V. Journal: Lung cancer Issue: Volume 108(2017) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer. (August 2019) Authors: Lindsay, C.R.; Blackhall, F.H.; Carmel, A.; Fernandez-Gutierrez, F.; Gazzaniga, P.; Groen, H.J.M.; Hiltermann, T.J.N.; Krebs, M.G.; Loges, S.; López-López, R.; Muinelo-Romay, L.; Pantel, K.; Priest, L.; Riethdorf, S.; Rossi, E.; Terstappen, L.; Wikman, H.; Soria, J.-C.; Farace, F.; Renehan, A. Journal: European journal of cancer Issue: Volume 117(2019) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. KRAS: Reasons for optimism in lung cancer. (August 2018) Authors: Lindsay, C.R.; Jamal-Hanjani, M.; Forster, M.; Blackhall, F. Journal: European journal of cancer Issue: Volume 99(2018) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Thymic malignancies: Moving forward with new systemic treatments. (May 2016) Authors: Remon, J.; Lindsay, C.R.; Bluthgen, M.V.; Besse, B. Journal: Cancer treatment reviews Issue: Volume 46(2016) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗